Initial clinical experience with extracorporeal shock wave therapy in treatment of ischemic heart failure

Congestive Heart Failure

Volumn 16, Issue 5, 2010, Pages 226-230

  Vasyuk, Yury A ^a   Hadzegova, Alla B ^a   Shkolnik, Evgeny L ^a   Kopeleva, Maya V ^a   Krikunova, Olga V ^a   Iouchtchouk, Elena N ^b   Aronova, Elena M ^b   Ivanova, Svetlana V ^a  

^a A I EVDOKIMOV MOSCOW STATE UNIVERSITY OF MEDICINE AND DENTISTRY   (Russian Federation)

^b Nuclear Medicine Department   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; TROPONIN T;

ACUTE HEART INFARCTION; ADULT; ANAMNESIS; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; DISEASE CLASSIFICATION; EXTRACORPOREAL SHOCK WAVE THERAPY; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HUMAN; LOW DRUG DOSE; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; SCORING SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS ECHOCARDIOGRAPHY; SYSTOLIC DYSFUNCTION; THERAPY EFFECT; ULTRASOUND THERAPY; UNITED STATES;

ECHOCARDIOGRAPHY, STRESS; EXERCISE TEST; HEART FAILURE; HUMANS; MYOCARDIAL ISCHEMIA; PAIN MEASUREMENT; SEVERITY OF ILLNESS INDEX; SHORT-WAVE THERAPY; STROKE VOLUME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME;

EID: 77957045904     PISSN: 15275299     EISSN: 17517133     Source Type: Journal    
DOI: 10.1111/j.1751-7133.2010.00182.x     Document Type: Article

References (18)

1. Lloyd-Jones D, Adams RJ, Brown TM. Heart Disease and Stroke Statistics-2010 Update A Report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2010, 121:e1-e170.
2. Volpi A, DeVita C, Franzosi G. Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis: results of the GISSI-2 data base. Circulation 1993, 88:416-429.
3. Rahimtoola SH. A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. Circulation 1985, 72(Suppl V):V123-V135.
4. Underwood SR, Bax JJ, vom Dahl J. Imaging techniques for the assessment of myocardial hibernation. Report of a Study Group of the European Society of Cardiology. Eur Heart J 2004, 25(10):815-836.
5. Hunt SA, Abraham WT, Chin MH. 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2009, 53:e1-e90.
6. Buszman P. Comparison of effectiveness of coronary artery bypass grafting versus percutaneous coronary intervention in patients with ischemic cardiomyopathy. Am J Cardiol. 2007, 99:36-41.
7. Fukumoto Y, Ito A, Uwatoku T. Extracorporeal cardiac shock wave therapy ameliorates myocardial ischemia in patients with severe coronary artery disease. Coron Artery Dis 2006, 17:63-70.
8. Khattab AA, Brodersen B, Schuermann-Kuchenbrandt D. Extracorporeal cardiac shock wave therapy: first experience in the everyday practice for treatment of chronic refractory angina pectoris. Int J Cardiol 2007, 1:84-85.
9. Kikuchi Y, Ito K, Ito Y. Double-blind and placebo-controlled study of the effectiveness and safety of extracorporeal cardiac shock wave therapy for severe angina pectoris. Circ J 2010, 74:589-591.
10. Reher P, Doan N, Bradnock B. Effect of Ultrasound on the Production of IL-8, basic FGF and VEGF. Cytokine 1999, 11(6):416-423.
11. Doan N, Reher P, Meghji S, Harris M. In vitro effects of therapeutic ultrasound on cell proliferation, protein synthesis, and cytokine production by human fibroblasts, osteoblasts and momocytes. J Oral Maxillofac Surg 1999, 57(4):409-419.
12. Young SR, Dyson M. The effect of therapeutic ultrasound on angiogenesis. Ultrasound Med Biol 1990, 16(3):261-269.
13. Nishida T, Shimokawa H, Oi K. Extracorporeal cardiac shock wave therapy markedly ameliorates ischemia-induced myocardial dysfunction in pigs in vivo. Circulation 2004, 110(19):3055-3061.
14. Mariotto S, Cavalieri E, Amelio E. Extracorporeal shock waves: from lithotripsy to anti-inflammatory action by NO production. Nitric Oxide 2005, 12(2):89-96.
15. Zimpfer D. Direct epicardial shock wave therapy improves ventricular function and induces angiogenesis in ischemic heart failure. J Thorac Cardiovasc Surg 2009, 137:963-970.
16. Auerbach MA, Schoder H, Hoh C. Prevalence of myocardial viability as detected by positron emission tomography in patients with ischemic cardiomyopathy. Circulation 1999, 99:2921-2926.
17. Cleland JG, Pennel D, Ray D. Prevalence of hibernation and reversible ischemia in patients with heart failure due to ischemic heart disease: baseline data from the CHRISTMAS study. Eur J Heart Fail 2001, 3:S75.
18. Allman KC, Shaw LJ, Hachamovitch R. Udelson Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002, 39(7):1151-1158.